Project profile — Supporting the provision of diagnostic toolkits to detect COVID-19

• Cambodia (3.71%)
• Congo, Democratic Republic (3.71%)
• Saint Lucia (3.70%)
• Mali (7.41%)
• Malaysia (3.70%)
• Tunisia (3.70%)
• Barbados (3.71%)
• Jordan (7.41%)
• Philippines (11.11%)
• Ethiopia (3.70%)
• Jamaica (3.70%)
• Cameroon (3.71%)
• Saint Vincent And The Grenadines (3.70%)
• Cuba (7.41%)
• Trinidad And Tobago (3.70%)
• Palau (3.70%)
• Sierra Leone (3.70%)
• Sudan (7.41%)
• Uganda (3.70%)
• Antigua and Barbuda (3.71%)
• Nigeria (3.70%)

• Health: COVID-19 control (12264) (100.00%)

This project funds the International Atomic Energy Agency (IAEA) to deliver diagnostic kits, equipment, and training in nuclear-derived detection techniques. This is to support countries asking for assistance to tackle the worldwide spread of the novel coronavirus causing COVID-19.

The expected outcome for this project includes 27 emergency assistance packages procured and delivered to 21 countries. These packages include real-time reverse transcription-polymerase chain reaction diagnostic machines, reagents, and laboratory materials for testing.

Results achieved as of the end of the project (September 2021) include: (1) delivered 27 emergency assistance packages to 23 national laboratories and institutions in 21 countries; (2) delivered nine reverse transcription-polymerase chain reaction diagnostic machines to three additional countries; and (3) delivered 30,000 testing kits to Cuba to increase their national diagnostic capacities.

• Proactive disclosure